1ob1
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:1ob1.jpg|left|200px]] | + | [[Image:1ob1.jpg|left|200px]] |
- | + | ||
- | '''CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19''' | + | {{Structure |
+ | |PDB= 1ob1 |SIZE=350|CAPTION= <scene name='initialview01'>1ob1</scene>, resolution 2.90Å | ||
+ | |SITE= | ||
+ | |LIGAND= <scene name='pdbligand=CAC:CACODYLATE ION'>CAC</scene> | ||
+ | |ACTIVITY= | ||
+ | |GENE= | ||
+ | }} | ||
+ | |||
+ | '''CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | 1OB1 is a [ | + | 1OB1 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Plasmodium_falciparum Plasmodium falciparum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1OB1 OCA]. |
==Reference== | ==Reference== | ||
- | Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate., Pizarro JC, Chitarra V, Verger D, Holm I, Petres S, Dartevelle S, Nato F, Longacre S, Bentley GA, J Mol Biol. 2003 May 16;328(5):1091-103. PMID:[http:// | + | Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate., Pizarro JC, Chitarra V, Verger D, Holm I, Petres S, Dartevelle S, Nato F, Longacre S, Bentley GA, J Mol Biol. 2003 May 16;328(5):1091-103. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12729744 12729744] |
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Plasmodium falciparum]] | [[Category: Plasmodium falciparum]] | ||
Line 32: | Line 41: | ||
[[Category: surface antigen]] | [[Category: surface antigen]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 13:08:19 2008'' |
Revision as of 11:08, 20 March 2008
| |||||||
, resolution 2.90Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | |||||||
Coordinates: | save as pdb, mmCIF, xml |
CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
Overview
Merozoite surface protein 1 (MSP1) is the major protein component on the surface of the merozoite, the erythrocyte-invasive form of the malaria parasite Plasmodium. Present in all species of Plasmodium, it undergoes two distinct proteolytic maturation steps during the course of merozoite development that are essential for invasion of the erythrocyte. Antibodies specific for the C-terminal maturation product, MSP1-19, can inhibit erythrocyte invasion and parasite growth. This polypeptide is therefore considered to be one of the more promising malaria vaccine candidates. We describe here the crystal structure of recombinant MSP1-19 from P.falciparum (PfMSP1-19), the most virulent species of the parasite in humans, as a complex with the Fab fragment of the monoclonal antibody G17.12. This antibody recognises a discontinuous epitope comprising 13 residues on the first epidermal growth factor (EGF)-like domain of PfMSP1-19. Although G17.12 was raised against the recombinant antigen expressed in an insect cell/baculovirus system, it binds uniformly to the surface of merozoites from the late schizont stage, showing that the cognate epitope is exposed on the naturally occurring MSP1 polypeptide complex. Although the epitope includes residues that have been mapped to regions recognised by invasion-inhibiting antibodies studied by other workers, G17.12 does not inhibit erythrocyte invasion or MSP1 processing.
About this Structure
1OB1 is a Single protein structure of sequence from Mus musculus and Plasmodium falciparum. Full crystallographic information is available from OCA.
Reference
Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate., Pizarro JC, Chitarra V, Verger D, Holm I, Petres S, Dartevelle S, Nato F, Longacre S, Bentley GA, J Mol Biol. 2003 May 16;328(5):1091-103. PMID:12729744
Page seeded by OCA on Thu Mar 20 13:08:19 2008
Categories: Mus musculus | Plasmodium falciparum | Single protein | Bentley, G A. | Chitarra, V. | Dartville, S. | Holm, I. | Longacre, S. | Nato, F. | Petres, S. | Pizarro, J C. | Verger, D. | CAC | Antibody fab fragment | Egf-like domain | Immunoglobulin | Malaria vaccine component | Merozoite surface protein 1 | Msp1-19 | Surface antigen